Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclizumab for Ocular Complications of Behcet's Disease
NCT00001865Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Jul 1999
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of daclizumab in Behcet's disease (BD), sponsored by National Eye Institute. Started Jul 1999; status: completed.
02
Drugs
daclizumab
03
Conditions
Behcet's disease (BD)
Beyond the preview
Go deeper on NCT00001865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001865.